Finch Therapeutics Group Inc. Gains 36.73%

Mon, Mar 11, 2024 at 07:16 PM
Finch Therapeutics Group Inc. Gains 36.73%

Finch Therapeutics Group Inc. (FNCH:NASDAQ) jumped higher at $3.42, a gain of 36.7%. On Mon, Mar 11, 2024, FNCH:NASDAQ hit a New 2-Week High of $3.42. From Mon, Feb 26, 2024, the stock recorded 50.00% Up Days and 54.55% Green Days

About Finch Therapeutics Group Inc. (FNCH:NASDAQ)

Finch Therapeutics Group Inc is a clinical-stage microbiome therapeutics company. It is leveraging Human-First Discovery platform to develop a novel class of orally administered biological drugs.

Get Lifetime 50% Off Premium Subscription
$19.99 USD
Limited-Time Discount
$9.99 USD
Signup 7 Days Trial. No Credit Card Required!
Ever wanted to explore stocks that have recently spiked... stocks moving sideways... gaps... or other trends? You're in the right place! Check StockTreats features.